Transforming Drug Discovery and Regenerative Medicine with EVOP: A Platform for Precision, Efficiency, and Insight

The primary challenge addressed by 3GO is the predictability gap in preclinical drug testing. Traditional models often fail to replicate full-organ function, leading to high failure rates during clinical trials. This shortcoming has been emphasized in the drug discovery landscape as a limiting factor in accelerating therapy development. Internal consultations with Dr. Rogers’ lab and conversations with academic lab collaborations, particularly those developing treatments for organ-targeted diseases, resonate with the need for models that deliver higher translational reliability, lower cost, and shorter development timelines.

Faculty Supervisor:

Ian Rogers

Student:

Partner:

3.G.O

Discipline:

Life Sciences

Sector:

Manufacturing

University:

University of Toronto

Program:

Business Strategy Internship

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects